Menu
Currency
GWAS Study

GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer.

Zhou W, Brumpton B, Kabil O et al.

32769997 PubMed ID
GWAS Study Type
119715 Participants
126 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

ZW
Zhou W
BB
Brumpton B
KO
Kabil O
GJ
Gudmundsson J
TG
Thorleifsson G
WJ
Weinstock J
ZM
Zawistowski M
NJ
Nielsen JB
CL
Chaker L
MM
Medici M
TA
Teumer A
NS
Naitza S
SS
Sanna S
SU
Schultheiss UT
CA
Cappola A
KJ
Karjalainen J
KM
Kurki M
OM
Oneka M
TP
Taylor P
FL
Fritsche LG
GS
Graham SE
WB
Wolford BN
OW
Overton W
RH
Rasheed H
HE
Haug EB
GM
Gabrielsen ME
SA
Skogholt AH
SI
Surakka I
DS
Davey Smith G
PA
Pandit A
RT
Roychowdhury T
HW
Hornsby WE
JJ
Jonasson JG
SL
Senter L
LS
Liyanarachchi S
RM
Ringel MD
XL
Xu L
KL
Kiemeney LA
HH
He H
NR
Netea-Maier RT
MJ
Mayordomo JI
PT
Plantinga TS
HJ
Hrafnkelsson J
HH
Hjartarson H
SE
Sturgis EM
PA
Palotie A
DM
Daly M
CC
Citterio CE
AP
Arvan P
BC
Brummett CM
BM
Boehnke M
DL
de la Chapelle A
SK
Stefansson K
HK
Hveem K
WC
Willer CJ
ÅB
Åsvold BO
Chapter II

Abstract

Summary of the research findings

Thyroid stimulating hormone (TSH) is critical for normal development and metabolism. To better understand the genetic contribution to TSH levels, we conduct a GWAS meta-analysis at 22.4 million genetic markers in up to 119,715 individuals and identify 74 genome-wide significant loci for TSH, of which 28 are previously unreported. Functional experiments show that the thyroglobulin protein-altering variants P118L and G67S impact thyroglobulin secretion. Phenome-wide association analysis in the UK Biobank demonstrates the pleiotropic effects of TSH-associated variants and a polygenic score for higher TSH levels is associated with a reduced risk of thyroid cancer in the UK Biobank and three other independent studies. Two-sample Mendelian randomization using TSH index variants as instrumental variables suggests a protective effect of higher TSH levels (indicating lower thyroid function) on risk of thyroid cancer and goiter. Our findings highlight the pleiotropic effects of TSH-associated variants on thyroid function and growth of malignant and benign thyroid tumors.

119,715 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

119715
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Norway, U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.